Taken together, these results suggest that in addition to pharmacological and surgical methods, the DASH diet maybe a potential strategy to reduce myostatin levels with concurrent parallel changes in adiposity that may in-turn benefit individulas with obesity. Here, MSTN is linked to obesity due to melanocortin 4 receptor deficiency.